249 related articles for article (PubMed ID: 9670628)
1. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
Kavishwar VS; Phatak AM; Rege JD
Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
[TBL] [Abstract][Full Text] [Related]
2. Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma.
Ueno K; Kobayashi T; Shimano T; Matsuura N; Monden T; Takeda T; Tomita N; Mori T
Med J Osaka Univ; 1994 Sep; 43(1-4):17-21. PubMed ID: 7609706
[TBL] [Abstract][Full Text] [Related]
3. Cancer of the thyroid--explorations of clinical biology.
Hennen G
Acta Chir Belg; 1994; 94(1):30-2. PubMed ID: 8184648
[TBL] [Abstract][Full Text] [Related]
4. Medullary and mixed medullary-papillary carcinoma of the thyroid gland.
Macák J; Vaverková H; Dushová M; Perglerová I
Pathologica; 1997 Jun; 89(3):317-22. PubMed ID: 9270266
[TBL] [Abstract][Full Text] [Related]
5. Medullary carcinoma of the thyroid: histomorphological, histochemical and immunohistochemical analysis of twenty cases.
Kos M; Separović V; Sarcević B
Acta Med Croatica; 1995; 49(4-5):195-9. PubMed ID: 8630453
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
[TBL] [Abstract][Full Text] [Related]
7. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoma of the thyroid gland with biphasic clinical course and evolution into medullary carcinoma, follicular variant. A case report and immunocytochemical demonstration of the simultaneous presence of calcitonin and thyroglobulin in neoplastic cells].
Carlei F; Famulari A; Muzi P; Sciaratta F; Mariani P; Lomanto D; D'Alessandro M
Minerva Chir; 1992 Apr; 47(8):773-5. PubMed ID: 1603426
[No Abstract] [Full Text] [Related]
9. A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components.
Apel RL; Alpert LC; Rizzo A; LiVolsi VA; Asa SL
Arch Pathol Lab Med; 1994 Nov; 118(11):1143-7. PubMed ID: 7979902
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors].
Cabaret V; Vilain MO; Delobelle-Deroide A; Vanseymortier L
Ann Pathol; 1992; 12(6):347-52. PubMed ID: 1294156
[TBL] [Abstract][Full Text] [Related]
11. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
Nasser SM; Pitman MB; Pilch BZ; Faquin WC
Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
[TBL] [Abstract][Full Text] [Related]
12. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 is a presurgical marker of human thyroid carcinoma.
Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
[TBL] [Abstract][Full Text] [Related]
14. Beta- and gamma-catenin expression in thyroid carcinomas.
Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
[TBL] [Abstract][Full Text] [Related]
15. [Histologic and immunohistochemical characterization of medullary thyroid carcinoma].
Abrosimov Aiu
Arkh Patol; 1996; 58(4):43-8. PubMed ID: 8967865
[TBL] [Abstract][Full Text] [Related]
16. [Tumor markers in medullary thyroid carcinoma. Biochemical and immunohistochemical study].
López-Guzmán A; Navarro E; Aramendi T
An Med Interna; 1996 Jul; 13(7):358-9. PubMed ID: 8962990
[No Abstract] [Full Text] [Related]
17. Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique.
Figge J; Bakst G; Weisheit D; Solis O; Ross JS
Am J Pathol; 1991 Dec; 139(6):1213-9. PubMed ID: 1721488
[TBL] [Abstract][Full Text] [Related]
18. Primary squamous-cell carcinoma of the thyroid gland: new evidence in support of follicular epithelial cell origin.
Sahoo M; Bal CS; Bhatnagar D
Diagn Cytopathol; 2002 Oct; 27(4):227-31. PubMed ID: 12357501
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical analysis of malignant tumors of the thyroid gland using 6 relevant markers].
Brasanac D; Jancić-Zgurics M; Janković R; Tatić S
Srp Arh Celok Lek; 1993; 121(3-7):70-3. PubMed ID: 7716641
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity?
Holm R; Sobrinho-Simões M; Nesland JM; Sambade C; Johannessen JV
Lab Invest; 1987 Sep; 57(3):258-68. PubMed ID: 3626517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
